Watchlist Price Alert

Virios Therapeutics Inc. (VIRI)

NASDAQ: VIRI · Real-Time Price · USD

0.15

0.01 (8.77%)

At close: Oct 08, 2024, 8:00 PM

Virios Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-4.68M	-5.07M	-5.3M	-6.24M	-7.58M	-9.8M	-12.25M	-14.71M	-16.25M	-16.86M	-15.96M	-17.95M	-16.56M	-12.94M	-10.35M	-4.48M	-2.57M	-2.48M	-2.53M	-1.89M	-1.08M	-511.61K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	53.98K	53.98K	53.98K	53.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	584.53K	597.24K	619.97K	621.2K	637.16K	612.45K	582.66K	565.03K	532.67K	429.96K	322.88K	5.62M	7.49M	7.45M	7.43M	2M	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-17.13K	302.12K	610.09K	327.12K	139.88K	-779.41K	-21.92K	12.77K	1.17M	3.49M	-322.2K	-731.84K	-1.71M	-3.74M	-1.03M	223.45K	435.84K	563.88K	406.3K	235.99K	-105.95K	-52.97K
Other Non-Cash Items	651.3K	535.58K	1.08M	1.06M	1.09M	808.05K	363.36K	402.8K	129.73K	713.93K	52.87K	-239.97K	1.86M	1.48M	2M	2.04M	36.76K	100.15K	98.15K	86.01K	73.68K	8.72K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-53.98K	-53.98K	-53.98K	-53.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-83.9K	363.79K	-194.45K	-456.53K	-654.63K	-1.32M	197.38K	175.01K	1.58M	3.2M	-52.19K	-436.78K	-1.62M	-3.23M	-974.06K	364.02K	504.42K	571K	339.58K	184.84K	-105.95K	-52.97K
Operating Cash Flow	-4.18M	-4.11M	-4.87M	-6.07M	-7.6M	-10.51M	-11.47M	-13.97M	-14.14M	-13.23M	-15.69M	-12.8M	-10.71M	-8.73M	-3.9M	-2.08M	-2.03M	-1.81M	-2.09M	-1.62M	-1.11M	-555.86K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	125K	831.63K	1.99M	2.57M	2.45M	1.74M	580K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-86	-86	-86	-86	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	295.95K	-1.16M	-1.16M	n/a	4.58M	4.58M	4.58M	4.58M	n/a	n/a	-97.6K	31.49M	31.37M	31.29M	31.39M	-201.17K	-96.48K	887.56K	1.79M	1.8M	1.81M	903.95K
Financial Cash Flow	4.92M	3.47M	3.47M	1.07M	4.49M	4.49M	4.49M	4.58M	n/a	n/a	-97.6K	31.49M	31.49M	32.12M	33.38M	2.37M	2.35M	2.63M	2.37M	1.8M	1.81M	903.95K
Net Cash Flow	-1.57M	-2.95M	-3.71M	-5M	-3.1M	-6.02M	-6.98M	-9.4M	-14.14M	-13.23M	-15.79M	18.69M	20.79M	23.39M	29.49M	292.41K	322.29K	816.39K	279.36K	176.64K	696.18K	348.09K
Free Cash Flow	-4.18M	-4.11M	-4.87M	-6.07M	-7.6M	-10.51M	-11.47M	-13.97M	-14.14M	-13.23M	-15.69M	-12.8M	-10.71M	-8.73M	-3.9M	-2.08M	-2.03M	-1.81M	-2.09M	-1.62M	-1.11M	-555.86K